Real-time ESG Scores

AbbVie Inc

AbbVie Inc is part of the Pharmaceuticals, Biotechnology & Life Sciences sector. The company has a ESG Pulse of 0.60 which is calculated using alternative data outside of company disclosure to provide an 'outside-in' view on company ESG performance.

AbbVie Inc., a research-based biopharmaceutical company, develops and markets pharmaceutical products in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a biologic therapy administered as an injection for autoimmune and intestinal diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty, and for the treatment of patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; and Janssen Biotech, Inc. The company was incorporated in 2012 and is based in North Chicago, Illinois.

ESG Pulse

ESG Pulse is ranked on a scale of -1 (negative) to +1 (good). This is the average sentiment of all items that have been classified as material ESG'
Updated on:
2022-04-12

Historical ESG Pulse

View historical company ESG pulse and compare against industry, overlay stock prices or view vs peers.

Materiality

View company ESG performance broken down by the 26 SASB topics.

Traditional ESG data doesn't give you the full picture

Old style esg data
The old way
Reliant on company disclosure and analysts
Traditional providers such as MSCI and Sustainalytics rely on company disclosure - which happens infrequently. They employ armies of analysts to gather this data.
  • ESG data and scores are stale (every 6-12 months)
  • Low amount company coverage
  • ESG data is extremely expensive
  • ESG data is not always transparent/objective
Real time esg score in chart
The new way
Dynamic, real-time ESG data
Alternative data such as news, media, job postings, social media and others - allow us to extract signals from the 'outside-in' using AI and fully automated approaches.
  • A check mark
    Real-time ESG data
  • A check mark
    Unlimited coverage of public/private companies
  • A check mark
    Affordable software for analysis
  • A check mark
    Explainable, transparent ESG
start Your 7-day Free trial